Apitegromab (SRK-015) is a new myostatin inhibitor, an antibody targeting myostatin precursor, which can be used to study neuromuscular diseases including spinal muscular atrophy.
Purity:
95.00%
CAS Number:
[2278276-46-1]
Target:
TGF-beta/Smad|||Opioid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted